Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)

NCT03674242 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decision

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: eryaspase (L-asparaginase encapsulated in red blood cells)
DRUG: Gemcitabine
DRUG: Carboplatin

Sponsor

ERYtech Pharma